Article
Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probes.
Clinica chimica acta; international journal of clinical chemistry - 20 Nov 2011
Howard Rebecca, Leathart Julian B S, French David J, Krishan Elaina, Kohnke Hugo, Wadelius Mia, van Schie Rianne, Verhoef Talitha, Maitland-van der Zee Anke-Hilse, Daly Ann K, Barallon Rita
Abstract excerpt
BACKGROUND: Coumarin anticoagulants such as warfarin are used to treat and prevent thromboembolic events in patients. The required dosage is difficult to predict and the risk of over or under anticoagulation are dependent on several environmental and clinical factors, such as concurrent medication, diet, age and genotype for polymorphisms in two genes CYP2C9 and VKORC1. METHODS: A novel fluorescent PCR genotyping...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
